822
Views
50
CrossRef citations to date
0
Altmetric
Original Articles

Derivation of an Oral Reference Dose (RfD) for the Nonphthalate Alternative Plasticizer 1,2-Cyclohexane Dicarboxylic Acid, Di-Isononyl Ester (DINCH)

, , &

REFERENCES

  • Web addresses were current at the time of publication. Although they may change, these addresses should provide some direction in obtaining online information.
  • Aristech Chemical Corporation 1994. 2-Year dietary oral toxicity study in rats with diisononyl phthalate. TSCA 8(e) submission 8EHQ-0794-13083. CAS number 68515-48-0. As cited in European Chemicals Agency (ECHA, 2013).
  • BASF AG. 1999a. 1,2-Cyclohexane dicarboxylic acid, di (isononyl) ester—Acute eye irritation in rabbits. Laboratory project identification: 11H0223/992126. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 1999b. 1,2-Cyclohexane dicarboxylic acid, di (isononyl) ester—Acute dermal irritation/corrosion in rabbits. Laboratory project identification: 18H0223/992125. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 1999c. Acute dermal irritation/corrosion in rabbits. Laboratory project identification: 18H0745/002210. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 1999d. 1,2-Cyclohexane dicarboxylic acid, di (isononyl) ester—Maximization test in guinea pigs. Laboratory project identification: 30H0223/992127. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 1999e. 1,2-Cyclohexane dicarboxylic acid, di (isononyl) ester—Acute oral toxicity in rats. Laboratory project identification: 10A0223/991059. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 1999f. 1,2-Cyclohexane dicarboxylic acid, di (isononyl) ester—Acute dermal toxicity in rats. Laboratory project identification: 11A0223/991060. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2000a. 1,2-Cyclohexane dicarboxylic acid, di (isononyl) ester—Repeated dose oral toxicity study in Wistar rats, Administration in the diet for 4 weeks and recovery period of 2 weeks. Final report. Project no. 37S0223/99062. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2000b. Salmonella typhimurium/Eschericia coli reverse mutation assay (standard plate test and preincubation test) with 1,2-cyclohexane dicarboxylic acid, di (isononyl) ester. Final report. Project no. 40MO223/994088. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Germany.
  • BASF AG. 2000c. In vitro chromosome aberration assay in Chinese hamster V79 cells with 1,2-cyclohexane dicarboxylic acid, di(isononyl) ester. Unpublished study conducted by RCC Cytotest Cell Research. RCC-CCR project 651400. ZHIT-Project no. 32MO2231999040. Sponsored by BASF Aktiengesellschaft, Germany.
  • BASF AG. 2001a. Acute dermal irritation/corrosion in rabbits. Laboratory project identification: 18H0745/002210. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2001b. In vitro gene mutation test with 1,2-cyclohexane dicarboxylic acid, di(isononyl) ester. Project no. 50M0107/014031. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2001c. Micronucleus assay in bone marrow cells of the mouse with 1,2-cyclohexane dicarboxylic acid, di(isononyl) ester. Unpublished study conducted by RCC Cytotest Cell Research. RCC-CCR project 698101. Sponsored by BASF AG, Ludwigshafen, Germany. BASF-project no. 26M01071019004.
  • BASF AG. 2002a. Plastisol Rezeptur (auf Basis Hexamoll DINCH®) Acute dermal irritation/corrosion in rabbits. Study no. 18H0084/022004. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2002b. 1,2-Cyclohexane dicarboxylic acid, di(isononyl) ester—Subchronic oral toxicity study in Wistar rats Administration in the diet for 3 months. Project no.: 50S0107/01009. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2002c. 1,2-Cyclohexane dicarboxylic acid, di(isononyl) ester—Pre-/postnatal developmental toxicity study in Wistar rats oral administration gavage. Laboratory project identification: 60R0223/99095. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2002d. 1,2-Cyclohexane dicarboxylic acid, di(isononyl) ester—Prenatel developmental toxicity study in Wistar rats oral administration. Project no. 30R0223/99124. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2003a. 14C-1,2-cyclohexanedicarboxylic acid, diisononyl ester—Study of the biokinetics in rats. Project no. 02B0608/016021. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2003b. 1,2-Cyclohexane dicarboxylic acid, di(isononyl) ester—Two generation reproduction toxicity study in Wistar rats continuous dietary administration. Laboratory project identification: 70 R01 07/01021. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2004a. 1,2-cyclohexane dicarboxylic acid, di(isononyl) ester—Prenatal developmental toxicity study in Himalayan rabbits administration in the diet. BASF project no. 42R0107/01135. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2004b. Hexamoll DINCH®—Acute dermal irritation/corrosion in rabbits. Project no. 18H0010/042033. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2005a. Investigations on the metabolism of 14C-1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH®) in rats. Final report. Study code: 197662. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2005b. 1,2-Cyclohexanedicarboxylic acid, diisononyl ester—Liver enzyme induction study in Wistar rats Administration in the diet over 2 weeks. Final report. Project no. 48C0107/01181. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2005c. 1,2-cyclohexane dicarboxylic acid, di(isononyl) ester—Thyroid function study in male Wistar rats using perchlorate discharge as a diagnostic test—Administration in the diet over 4 weeks. Laboratory project identification: 48C0107/01180. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2005d. 1,2-Cyclohexanedicarboxylic acid, diisononyl ester—Combined chronic toxicity/carcinogenicity study in CrlGlxBrlHan: WI-rats; Administration in the diet up to 24 months. Project no. 82S0107/01094. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF AG. 2005e. 1,2-Cyclohexanedicarboxylic acid, diisononyl ester—S-Phase response study in the liver of Wistar rats: Administration in the diet for 1, 4 and 13 weeks. Final report. Project no. 99S0107/01082. Unpublished study conducted and sponsored by BASF Aktiengesellschaft, Ludwigshafen, Germany.
  • BASF. 2007. New release: Science around us—A plasticizer for sensitive applications. June. http://www.basf.com/group/corporate/en/news-and-media-relations/science-around-us/plasticizer/index
  • BASF. 2013. Hexamoll®DINCH®—1,2-Cyclohexane dicarboxylic acid, di-isononyl ester. Technical data sheet. January. http://www2.basf.us/plasticizers/pdfs/products/TDS_DINCH®.pdf
  • Branch, R. A., Shand, D. G., Wilkinson, G. R., and Nies, A. S. 1974. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey: Relative contributions of enzyme induction and increased hepatic blood flow. J. Clin. Invest. 53: 1101–1107.
  • Capen, C. C. 1997. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol. Pathol. 25: 39–48.
  • Capen, C. C. 2006. Expert opinion on proliferative lesions of the thyroid follicular cells from Wistar rats administered Hexamoll DINCH® in the diet for two years (Carcinogenicity study no. 01094). Unpublished report submitted to NSF International by BASF Corporation, Wyandotte, MI.
  • European Chemicals Agency. 2013. Final review report. Evaluation of new scientific evidence concerning DINP and DIDP in relation to entry 52 of Annex XVII to Regulation (EC) No 1907/2006 (REACH). August. http://echa.europa.eu/documents/10162/31b4067e-de40-4044-93e8-9c9ff1960715 (accessed September 16, 2013).
  • European Food Safety Authority. 2006. Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request related to a 12th list of substances for food contact materials. EFSA J. 395–401:1–21.
  • Experimental Pathology Laboratories, Inc. 2008. Pathology peer review of mammary glands from a chronic feeding study in rats with 1,2-cyclohexanedicarboxylic acid, diisononyl ester-combined chronic toxicity/carcinogenicity study in CrlGlxBrlHan: Wl-Rats:Administration in the diet up to 24 months. EPL project no. 717-008. Unpublished report submitted to NSF International by BASF Corporation, Wyandotte, MI.
  • Exxon Biomedical Sciences 1986. Chronic toxicity/oncogenicity study in F-344 rats. Test material: MRD-83-260. Project no 326075 performed at Exxon Biomedical Sciences, Inc. Unpublished laboratory report. As cited in ECHA (2013).
  • Fisher, J., A. Lumen, J. Latendresse, and D. Mattie. 2012. Extrapolation of hypothalamic-pituitary-thyroid axis perturbations and associated toxicity in rodents to humans: Case study with perchlorate. J. Environ. Sci. Health C Environ. Carcinogen. Ecotoxicol. Rev. 30: 81–105.
  • Gilbert, M. E. and Zoeller, R. T. 2010. Thyroid hormone- impact on the developing brain: Possible mechanisms of neurotoxicity. In Neurotoxicology, 3rd edition, Target Organ Toxicology Series, ed. G. J. Harryand H. A. Tilson, 79–111. New York, NY: Informa Healthcare, USA.
  • Harvey, P. W. 2005. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: Prolactin involvement in human breast cancer and significance for toxicology risk assessments. J. Appl. Toxicol. 25: 179–183.
  • Harvey, P. W., Everett, D. J., and Springall, C. J. 2008. Adverse effects of prolactin in rodents and humans: Breast and prostate cancer. J. Psychopharmacol. 22: 20–27.
  • Hill, R. N., Crisp, T. M., Hurley, P. M., Rosenthal, S. L., and Singh, D. V. 1998. Risk assessment of thyroid follicular cell tumors. Environ. Health Perspect. 106: 447–457.
  • Hinton, R. H., Mitchell, F. E., Mann, A., Chescoe, D., Price, S. C., Nunn, A., Grasso, P., and Bridges, J. W. 1986. Effects of phthalic acid esters on the liver and thyroid. Environ. Health Perspect. 70: 195–210.
  • Howarth, J. A., Price, S. C., Dobrota, M., Kentish, P. A., and Hinton, R. H. 2001. Effects on male rats of di-(2-ethylhexyl)phthalate and di-n-hexylphthalate administered alone or in combination. Toxicol. Lett. 121: 35–43.
  • Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., Roberts, R. A., and Fenner-Crisp, P. A. 2003. PPARalpha agonist induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33: 655–780.
  • Koch, H.M., A. Schutze, C. Palmke, J. Angerer, and T. Bruning. 2013. Metabolism of the plasticizer and phthalate substitute diisononyl-cyclohexane-1,2-dicarboxylate (DINCH®) in humans after single oral doses. Arch. Toxicol. 87: 799–806.
  • Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., and Corton, J. C. 2005. Role of PPARα in mediating the effects of phthalates and metabolites in the liver. Toxicology 207: 149–163.
  • Lovekamp-Swan, T. and Davis, B. J. 2003. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ. Health Perspect. 111: 139–145.
  • Lyche, J. L., Gutleb, A. C., Bergman, A., Eriksen, G. S., Murk, A. J., Ropstad, Saunders, M., and Skaare, J. U. 2009. Reproductive and developmental toxicity of phthalates. J. Toxicol. Environ. Health B 12: 225–249.
  • Mann, P. C., Boorman, G. A., Lollini, L. O., McMartin, D. N., and Goodman, D. G. 1996. Proliferative lesions of the mammary gland in rats. IS-2. In Guides for toxicologic pathology. STP/ARP/AFIP, Washington, DC. http://www.toxpath.org/ssdnc/MammaryProliferativeRat.pdf
  • Matsumoto, M., Hirata-Koizumi, M., and Ema, M. 2008. Potential adverse effects of phthalic acid esters on human health: A review of recent studies on reproduction. Regul. Toxicol. Pharmacol. 50: 37–49.
  • McClain, R. M. 1989. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Enzyme Inducers Thyroid Neoplasia 17: 294–306.
  • Nagorka, R., Conrad, A., Scheller, C., Süßenbach, B., and Moriske, H. J. 2011. Diisononyl 1,2-cyclohexanedicarboxylic acid (DINCH®) and Di(2-ethylhexyl) terephthalate (DEHT) in indoor dust samples: Concentration and analytical problems. Int. J. Hyg. Environ. Health 214: 26–35.
  • National Industrial Chemicals Notification and Assessment Scheme. 2012a. Full public report. 1,2-Cyclohexanedicarboxylic acid, 1,2-diisononyl ester (Hexamoll DINCH®). Sydney, Australia, February. http://www.nicnas.gov.au/PUBLICATIONS/CAR/NEW/EX/EXFULLR/EX0000FR/ex170fr.pdf (accessed May 24, 2013).
  • National Industrial Chemicals Notification and Assessment Scheme. 2012b. Priority existing chemical assessment report no. 35. Diisononyl phthalate. Sydney, Australia, September. http://www.nicnas.gov.au/chemical-information/pec-assessments
  • Organization for Economic Cooperation and Development. 2006. OECD series on testing and assessment. number 57: Detailed review paper on thyroid hormone disruption assays. ENV/JM/MONO(2006)24. August. http://www.oecd.org/chemicalsafety/testing/37235405.pdf
  • Organization for Economic Cooperation and Development. 2013. OECD guidelines for the testing of chemicals. Section 4: Health effects. http://www.oecd-ilibrary.org (accessed May 7, 2013).
  • Ohnhaus, E. E., and Studer, H. 1983. A link between liver microsomal enzyme activity and thyroid hormone metabolism in man. Br. J. Clin. Pharmacol. 15: 71–76.
  • Price, S. C., Chescoe, D., Grasso, P., Wright, M., and Hinton, R. H. 1988. Alterations in the thyroids of rats treated for long periods with di-2-(ethylhexyl)phthalate or with hypolipidaemic agents. Toxicol. Lett. 40: 37–46.
  • Rice, J. M., Baan, R. A., Blettner, M., Genevois-Charmeau, C., Grosse, Y., McGregor, D. B., Partensky, C., and Wilbourn, J. D. 1999. Rodent tumors of urinary bladder, renal cortex, and thyroid gland in IARC monographs evaluations of carcinogenic risk to humans. Toxicol. Sci. 49: 166–171.
  • Russo, I. H., and Russo, J. 1996. Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 104: 938–967.
  • Schutze, A., Palmke, C., Angerer, J., Weiss, T., Bruning, T., and Koch, H. M. 2012. Quantification of biomarkers of environmental exposure to di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH®) in urine via HPLC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 895–896:123–130.
  • Schutze, A., Kolossa-Gehring, M., Apel, P., Brüninga, T., and Koch, H. M. 2013. Entering markets and bodies: Increasing levels of the novel plasticizer Hexamoll® DINCH® in 24 h urine samples from the German Environmental Specimen Bank. Int. J. Hyg. Environ. Health. 217: 421–426.
  • Scientific Committee on Emerging and Newly-Identified Health Risks. 2007. Preliminary report on the safety of medical devices containing DEHP plasticized PVC or other plasticizers on neonates and other groups possibly at risk. European Commission Health and Consumer Protection DG. June 21–22.http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_014.pdf
  • Silva, M. J., Furr, J., Preau, J. L., Jr., Samandar, E., Gray, L. E., and Calafat, A. M. 2012. Identification of potential biomarkers of exposure to di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH), an alternative for phthalate plasticizers. J. Expos. Sci. Environ. Epidemiol. 22: 204–211.
  • Silva, M. J., Jia, T., Samandar, E., Preau, J. L., and Calafat, A. M. 2013. Environmental exposure to the plasticizer 1,2-cyclohexane dicarboxylic acid, diisononyl ester (DINCH) in US adults (2000-2012). Environ. Res. 126: 159–163.
  • Svardal, A. M., and Scheline, R. R. 1985. The aromatization of cyclohexanecarboxylic acid to hippuric acid: substrate specificity and species differences. Mol. Cell. Biochem. 67: 171–179. As reviewed by NICNAS (2012a).
  • Thayer, K. A. and Foster, P. M. 2007. Workgroup report: National Toxicology Program Workshop on hormonally induced reproductive tumors—Relevance of rodent bioassays. Environ. Health Perspect. 115: 1351–1356.
  • University of New Hampshire. 2002. Pollution prevention framework: Level 1 screening-level chemical profile for BASF Corporation. Unpublished report submitted to NSF International by BASF Corporation, Wyandotte, MI.
  • U.S. Consumer Product Safety Commission. 2010. Review of exposure and toxicity data for phthalate substitutes. Prepared by Versar and SRC (Syracuse Research Corporation) for U.S. Consumer Product Safety Commission, Bethesda, MD. http://www.cpsc.gov/PageFiles/126546/phthalsub.pdf
  • U.S. Environmental Protection Agency. 1998. Assessment of thyroid follicular cell tumors. U.S. Environmental Protection Agency, Washington, DC, EPA/630/R-97/002. http://www.epa.gov/raf/publications/thyroid-follicular-cell-tumor.htm
  • U.S. Environmental Protection Agency. 2002. A review of the reference dose and reference concentration process. EPA/630/P-02/002F. December. U.S. EPA, Risk Assessment Forum, Washington, DC.
  • U.S. Environmental Protection Agency. 2005. Guidelines for carcinogen risk assessment. EPA/630/P-03/001B. March. http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=116283
  • U.S. Environmental Protection Agency. 2011a. Glossary of IRIS terms. Integrated Risk Information System (IRIS). Last updated August 2011. http://www.epa.gov/ngispgm3/iris/gloss8.htm
  • U.S. Environmental Protection Agency. 2011b. Recommended use of body weight ¾ as the default method in derivation of the oral reference dose. U.S. Environmental Protection Agency, Risk Assessment Forum, Washington, DC, EPA/100/R11/0001. http://www.epa.gov/raf/publications/interspecies-extrapolation.htm
  • U.S. Environmental Protection Agency. 2012. Office of the Science Advisor (OSA). Risk Assessment Forum publications—Human health. http://www.epa.gov/raf/pubhumanhealth.htm (accessed May 7, 2013).
  • U.S. Environmental Protection Agency. 2013a. Health effects testing guidelines. U.S. Code of Federal Regulations, Title 40, Part 798. U.S. Environmental Protection Agency, Washington, DC.
  • U.S. Environmental Protection Agency. 2013b. Benchmark Dose Software Beta Version 2.4.National Center for Environmental Assessment, Office of Research and Development. http://www.epa.gov/ncea/bmds.htm
  • U.S. Food and Drug Administration. 2013. U.S. Code of Federal Regulations, Title 21 (Food and Drugs). http://www.access.gpo.gov/nara/cfr/cfr-table-search.html
  • Viertel, B., and Trieb, G. 2003. The Himalayan rabbit (Oryctolagus cuniculue L.): Spontaneous incidences of endpoints from prenatal developmental toxicity studies. Lab. Anim. 37: 19–36.
  • Welle, F., Wolz, G., and Franz, R. 2005. Migration of plasticizers from PVC tubes into enteral feeding solutions. Pharma Int. 3: 17–24.
  • World Health Organization/International Programme on Chemical Safety. 2005. Chemical-specific adjustment factors for interspecies differences and human variability: Guidance document for use of data in dose/concentration-response assessment. World Health Organization/International Programme on Chemical Safety. World Health Organization, Geneva, Switzerland.
  • Zoeller, R. T., Tyl, R. W., and Tan, S. W. 2007. Current and potential rodent screens and tests for thyroid toxicants. Crit. Rev. Toxicol. 37: 55–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.